主动脉位置同种瓣膜:27年单中心前瞻性研究
该单中心前瞻性研究纳入1987—2010年353例主动脉瓣置换使用同种瓣膜患者,平均随访12年,20年累计生存率41%,结构性瓣膜衰败为主要再手术原因,年轻年龄与再手术增加相关。
要点
- 同种瓣膜长期结构性衰败常见,再手术风险随年轻年龄增加
- 随访中左室扩张和重度主动脉瓣反流与死亡相关
- 复杂主动脉根部病变和活动性心内膜炎仍可考虑同种瓣膜
核心结论
- 经过近30年经验,同种瓣膜在主动脉位置的适应证已趋于选择化,主要因随时间进展的结构性瓣膜衰败;复杂主动脉根部病变和活动性心内膜炎时同种瓣膜仍可能有用。
研究设计与样本
- 1987—2010年单中心前瞻性研究,353例患者接受同种瓣膜主动脉瓣置换,其中92例瓣下植入、261例根部替换,98%为主动脉同种瓣膜;平均年龄45岁,71%为男性;平均随访12年,99%完整;采用联合建模分析超声变量对死亡和再手术风险的影响。
主要发现
- 院内死亡5.9%(n=21);随访期间113例死亡,20年累计生存率41%(95%CI 32-50)。
- 117例发生瓣膜相关再手术:100例结构性瓣膜衰败、9例非结构性瓣膜衰败、8例心内膜炎。
- 竞争风险分析预测20年时31%死亡,30%存活且未再手术;年轻患者年龄与再手术增加相关。
- 随访中左室扩张和重度主动脉瓣反流与死亡相关(P=.006和.005),随访中3级或以上主动脉瓣反流与再手术风险相关(P=.001)。
临床怎么用
- 同种瓣膜用于主动脉位置时应选择性应用,尤其需考虑年轻患者结构性衰败和再手术风险。
- 复杂主动脉根部病变和活动性心内膜炎患者仍可考虑使用同种瓣膜。
- 术后随访应关注左室扩张和主动脉瓣反流程度,因其与死亡和再手术风险相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Over the past decades, the indication for allograft implantation in aortic position has evolved. The purpose of this study is to report long-term survival, allograft durability, and potential risk factors. METHODS: Between 1987 and 2010, 353 patients underwent aortic valve replacements via allograft (92 subcoronary, 261 root replacement; 98% aortic allografts). Patient characteristics, survival, valve durability, and valve-related events were analyzed. Patients also were followed with standardized echocardiography. A joint modeling approach was used to detect the effect of (echocardiographic) variables on mortality and reoperation hazard. RESULTS: Mean age was 45 years (range, 1 month to 84 years); 71% were males. The etiology was endocarditis in 32% (active 22%), congenital 31%, degenerative 9%, aneurysm/dissection 12%, rheumatic 6%, and prosthetic valve failure 10%. Hospital mortality was 5.9% (n = 21). During follow-up (mean 12 years, range, 0-24; 99% complete), 113 patients died. Twenty-year cumulative survival was 41% (95% confidence interval, 32-50). Valve-related reoperations occurred in 117 patients: 100 structural valve deterioration, 9 nonstructural valve deterioration, and 8 endocarditis. Competing-risk analysis predicted that at 20 years 31% died, and 30% were alive without reoperation. Younger patient age was associated with increased reoperation. During follow-up left ventricular dilatation and severe aortic regurgitation were associated with mortality (P = .006 and .005, respectively), and grade 3 or greater aortic regurgitation during follow-up was associated with risk of reoperation (P = .001). CONCLUSIONS: After almost 3 decades of experience with allografts in aortic position, the indication for use has become selective, mainly because of progressive structural valve deterioration over time. In case of complex aortic root pathology and active endocarditis allografts may still be useful.
引用
- Arabkhani B, Bekkers JA, Andrinopoulou ER, et al. Allografts in aortic position: Insights from a 27-year, single-center prospective study. J Thorac Cardiovasc Surg. 2016. PMID: 27842683. doi:10.1016/j.jtcvs.2016.08.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。